Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroblastoma × Vaccines, DNA × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Dysplasia 1 Triple Negative Breast Neoplasms 1 Sexually Transmitted Diseases, Viral 1 Prostatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neuroblastoma 1 High Grade Cervical Intraepithelial Neoplasia 1 Head and Neck Neoplasms 1

Interventions

Cyclophosphamide 81 Etoposide 44 Temozolomide 37 Carboplatin 37 Filgrastim 36 Topotecan 35 Melphalan 35 Isotretinoin 35 Irinotecan 35 Vincristine 34 Doxorubicin 33 3-Iodobenzylguanidine 30 Granulocyte Colony-Stimulating Factor 26 Cisplatin 25 Peripheral Blood Stem Cell Transplantation 24 sargramostim 21 dinutuximab 21 Granulocyte-Macrophage Colony-Stimulating Factor 21 Radiotherapy 20 Busulfan 18 fludarabine 16 Magnetic Resonance Spectroscopy 16 naxitamab 14 aldesleukin 13 Thiotepa 13 Interleukin-2 13 fludarabine phosphate 12 humanized 3F8 anti-GD2 monoclonal antibody 11 etoposide phosphate 11 Biopsy 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04049864 2022-03-02

DNA Vaccination Against Neuroblastoma

Belarusian Research Center for Pediatric Oncology, Hematology and Immunology

Phase EARLY_PHASE1 Unknown

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡